Health Care [ 4/12 ] | Pharmaceuticals [ 14/72 ]
NYSE MKT | Common Stock
NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and sells eyecare, skincare, and wound care products in the United States and internationally.
It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands.
The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand.
It sells its products through traditional and digital beauty retailers and distributors, as well as online.
The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007.
NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 9, 24 | -0.15 Increased by +82.35% | -0.15 |
| Mar 26, 24 | -1.33 Decreased by -70.51% | -0.30 Decreased by -343.33% |
| Nov 9, 23 | -0.37 Increased by +89.43% | -0.40 Increased by +7.50% |
| Aug 10, 23 | -0.64 Increased by +54.29% | -0.56 Decreased by -14.29% |
| May 11, 23 | -0.85 Increased by +51.43% | -0.91 Increased by +6.59% |
| Mar 30, 23 | -0.78 Decreased by -11.43% | -0.17 Decreased by -358.82% |
| Nov 14, 22 | -3.50 Decreased by -100.00% | -1.23 Decreased by -184.55% |
| Aug 11, 22 | -1.40 Increased by 0.00% | -1.23 Decreased by -13.82% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 3.25 M Decreased by -14.92% | -1.76 M Increased by +69.67% | Decreased by -53.98% Increased by +64.35% |
| Jun 30, 23 | 4.61 M Increased by +51.40% | -4.03 M Decreased by -87.10% | Decreased by -87.46% Decreased by -23.58% |
| Mar 31, 23 | 3.12 M Increased by +18.83% | -1.74 M Decreased by -1.47 K% | Decreased by -55.67% Decreased by -1.22 K% |
| Dec 31, 22 | 3.64 M Increased by +37.94% | -8.21 M Decreased by -818.92% | Decreased by -225.25% Decreased by -566.18% |
| Sep 30, 22 | 3.83 M Increased by +107.93% | -5.79 M Decreased by -153.08% | Decreased by -151.41% Decreased by -21.71% |
| Jun 30, 22 | 3.04 M Increased by +42.76% | -2.15 M Decreased by -15.92% | Decreased by -70.77% Increased by +18.80% |
| Mar 31, 22 | 2.63 M Increased by +45.49% | -111.00 K Increased by +92.69% | Decreased by -4.22% Increased by +94.97% |
| Dec 31, 21 | 2.64 M Increased by +39.88% | -893.00 K Increased by +49.09% | Decreased by -33.81% Increased by +63.60% |